Today, Johnson & Johnson shared its 2020 fourth-quarter and full-year earnings report.
Since its founding in 1886, the company has grown to become one of the world’s largest and most broad-based healthcare companies, with approximately 135,000 employees across the globe working every day to help change the trajectory of health for humanity.
“We achieved notable financial and operational performance in 2020 despite the many challenges and uncertainties presented by the global pandemic,” says Joe Wolk, Executive Vice President, Chief Financial Officer, Johnson & Johnson. “This is a true testament to the strength and resilience of our broad-based business and the dedication of our global Johnson & Johnson colleagues to deliver on our commitments to patients and customers. Our unbridled focus and ability enabled us to stay the course across our three business segments to advance breakthrough innovation. Simultaneously, we advanced our COVID-19 vaccine candidate and look forward to sharing Phase 3 data soon. Johnson & Johnson is poised for future strong performance as we work to continue delivering better health solutions for everyone, everywhere.”
For more details about the company’s 2020 fourth-quarter and full-year results, and to read a message from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic packed with key stats.
Johnson & Johnson’s 2020 Earnings
Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.
